Bo Zhou Selected Research

Catechols

9/2020	Inhibiting NF-κB-Mediated Inflammation by Catechol-Type Diphenylbutadiene via an Intracellular Copper- and Iron-Dependent Pro-Oxidative Role.
8/2019	Identification of Catechol-Type Diphenylbutadiene as a Tyrosinase-Activated Pro-oxidative Chemosensitizer against Melanoma A375 Cells via Glutathione S-Transferase Inhibition.
12/2015	Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Zhou Research Topics

Disease

157	Neoplasms (Cancer) 09/2022 - 05/2002
28	Infections 01/2022 - 03/2006
27	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2009
27	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2002
22	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2007
20	Carcinogenesis 01/2022 - 09/2007
19	Inflammation (Inflammations) 01/2022 - 01/2012
19	Insulin Resistance 01/2021 - 03/2013
18	Ovarian Neoplasms (Ovarian Cancer) 12/2020 - 12/2007
16	Stroke (Strokes) 01/2022 - 05/2007
15	Carcinoma (Carcinomatosis) 01/2020 - 10/2007
14	Lung Neoplasms (Lung Cancer) 01/2018 - 06/2009
12	Hypertension (High Blood Pressure) 01/2022 - 05/2007
11	Body Weight (Weight, Body) 01/2022 - 01/2008
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2006
11	Hemolysis 12/2018 - 08/2004
10	Wounds and Injuries (Trauma) 01/2022 - 12/2011
10	Leukemia 01/2021 - 12/2006
10	Obesity 01/2021 - 01/2008
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 09/2008
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2014
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2007
8	Ischemia 01/2022 - 06/2008
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2013
8	Fistula 02/2021 - 09/2013
8	Pancreatitis 03/2020 - 01/2013
7	Pain (Aches) 01/2022 - 04/2009
7	Panic Disorder (Panic Attack) 01/2022 - 01/2019
7	Sepsis (Septicemia) 01/2022 - 01/2013
7	Atherosclerosis 01/2022 - 01/2007
7	Hemorrhage 11/2021 - 08/2014
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
7	Necrosis 10/2020 - 02/2015
7	Cognitive Dysfunction 01/2020 - 09/2012
7	Melanoma (Melanoma, Malignant) 08/2019 - 02/2014
6	Myocardial Infarction 01/2022 - 10/2008
6	Liver Neoplasms (Liver Cancer) 01/2020 - 03/2012
5	Adenocarcinoma 09/2022 - 09/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 09/2008
5	Fibrosis (Cirrhosis) 01/2022 - 06/2014
5	Osteoporosis 01/2022 - 01/2015
5	Primitive Neuroectodermal Tumors (PNET) 03/2021 - 07/2017
5	Cysts 01/2021 - 02/2008
5	Hypersensitivity (Allergy) 01/2021 - 07/2002
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2015
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 03/2013

Drug/Important Bio-Agent (IBA)

54	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
24	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2008
20	Pharmaceutical PreparationsIBA 01/2022 - 07/2008
19	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2013
16	Biological ProductsIBA 06/2022 - 04/2006
16	AntioxidantsIBA 03/2021 - 08/2004
15	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2006
15	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2008
14	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 05/2013
13	Insulin (Novolin)FDA Link 01/2021 - 03/2013
12	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2009
11	Messenger RNA (mRNA)IBA 01/2019 - 12/2011
10	CurcuminIBA 03/2022 - 11/2013
10	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2008
10	ResveratrolIBA 03/2020 - 03/2009
9	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2014
9	CopperIBA 01/2022 - 12/2015
9	SodiumIBA 01/2022 - 01/2009
9	SaltsIBA 01/2022 - 07/2016
9	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 06/2012
9	TunicamycinIBA 11/2017 - 06/2013
8	Peptides (Polypeptides)IBA 01/2022 - 01/2007
8	EnzymesIBA 01/2022 - 09/2007
8	Long Noncoding RNAIBA 01/2022 - 09/2016
8	LipidsIBA 01/2021 - 01/2008
8	catechol (pyrocatechol)IBA 09/2020 - 08/2014
7	Phosphotransferases (Kinase)IBA 01/2022 - 10/2002
7	LigandsIBA 05/2018 - 01/2008
6	Circular RNAIBA 09/2022 - 01/2019
6	oxidized low density lipoproteinIBA 01/2022 - 08/2004
6	Glutathione (Reduced Glutathione)IBA 01/2022 - 04/2010
6	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 05/2002
6	Therapeutic UsesIBA 01/2021 - 04/2009
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2008
6	quinone (benzoquinone)IBA 09/2020 - 12/2015
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 05/2002
6	ProgranulinsIBA 01/2017 - 09/2014
6	2,2'-azobis(2-amidinopropane) (ABAP)IBA 06/2013 - 08/2004
5	Oxygen (Dioxygen)IBA 04/2022 - 08/2004
5	IonsIBA 01/2022 - 04/2009
5	AntigensIBA 01/2022 - 11/2013
5	TeaIBA 02/2021 - 08/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2009

Therapy/Procedure

47	Therapeutics 01/2022 - 02/2008
24	Drug Therapy (Chemotherapy) 06/2021 - 07/2002
8	Radiotherapy 10/2021 - 10/2012
7	Perforator Flap 10/2021 - 10/2016
7	Lasers (Laser) 01/2019 - 04/2009
6	Neoadjuvant Therapy 01/2021 - 05/2002
6	Chemoprevention 01/2019 - 04/2009
6	Length of Stay 12/2018 - 03/2012
5	Mammaplasty (Breast Reconstruction) 06/2022 - 01/2018
5	Stents 02/2021 - 01/2013